Akili Interactive To Become Publicly Traded Through SPAC Combination

On January 26, 2022, Akili Interactive, which develops digital health technology to treat cognitive impairments, announced it entered into an agreement to become publicly traded via a merger with Social Capital Suvretta Holdings Corp. I (SCS), a special purpose acquisition company (SPAC). The proposed combination has been unanimously approved by the boards of directors of both Akili and SCS and is expected to close in mid-2022. Once the deal closes, Akili will become part of SCS, which is a publicly traded company.

After the transaction is complete, Akili intends to launch commercial sales of its flagship product, EndeavorRx® a . . .